Drug Profile
Terbequinil
Alternative Names: SR 25776Latest Information Update: 07 Jan 1997
Price :
$50
*
At a glance
- Originator Sanofi-Synthelabo
- Class Antidementias; Antiepileptic drugs; Neuroprotectants
- Mechanism of Action GABA A receptor inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders; Major depressive disorder
Most Recent Events
- 07 Jan 1997 Discontinued-I for Depression in France (Unknown route)
- 12 Aug 1996 Discontinued-I for Cognition disorders in France (Unknown route)